BOLD vs OKE · P/E 0.1, $24.6M cap vs P/E 15, rev $21.70B
Boundless Bio, Inc. Common Stock (BOLD) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
BOLD does not have a complete income-statement cache yet.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the BOLD and OKE stock pages for the full models.
Not investment advice.